Joe Stephenson Selected Research

Joe Stephenson Research Topics

Disease

10	Neoplasms (Cancer) 10/2017 - 09/2008
3	Colorectal Neoplasms (Colorectal Cancer) 05/2015 - 06/2011
3	Neutropenia 02/2015 - 09/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2012 - 09/2008
2	Melanoma (Melanoma, Malignant) 08/2010 - 07/2009
1	Fatigue 10/2017
1	Edema (Dropsy) 10/2017
1	Nausea 10/2017
1	Hypoxia (Hypoxemia) 05/2015
1	Cholecystitis 05/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2015
1	Cytopenia 03/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2015
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Cardiotoxicity 03/2013
1	Disease Progression 01/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2013
1	Thrombocytopenia (Thrombopenia) 01/2013
1	Carcinogenesis 06/2012
1	Prostatic Neoplasms (Prostate Cancer) 09/2011
1	Weight Loss (Weight Reduction) 06/2011
1	Vomiting 06/2011
1	Headache (Headaches) 06/2011
1	Fever (Fevers) 06/2011
1	Diarrhea 06/2011
1	Colic (Abdominal Cramps) 06/2011

Drug/Important Bio-Agent (IBA)

4	Gemcitabine FDA Link 05/2015 - 01/2011
3	Panitumumab (Vectibix)FDA Link 05/2015 - 01/2011
3	Cisplatin (Platino)FDA LinkGeneric 02/2015 - 07/2009
2	motesanib diphosphateIBA 05/2015 - 01/2011
2	DNA (Deoxyribonucleic Acid)IBA 05/2015 - 06/2012
2	Monoclonal AntibodiesIBA 03/2015 - 08/2014
2	Docetaxel (Taxotere)FDA Link 02/2015 - 09/2011
2	Pharmaceutical PreparationsIBA 02/2015 - 01/2013
2	ErbB Receptors (EGF Receptor)IBA 08/2014 - 08/2011
1	Alkaline PhosphataseIBA 10/2017
1	Macrophage Colony-Stimulating FactorIBA 10/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2017
1	Angiogenesis InhibitorsIBA 05/2015
1	isophosphamide mustard (IPAM)IBA 05/2015
1	TH 302IBA 05/2015
1	Alkylating AgentsIBA 05/2015
1	ProdrugsIBA 05/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2015
1	Lenalidomide (CC 5013)FDA Link 03/2015
1	ofatumumab FDA Link 03/2015
1	SodiumIBA 02/2015
1	Temozolomide (Temodar)FDA LinkGeneric 02/2015
1	AlbuminsIBA 02/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2015
1	N- ((5- bromo- 2- thienyl)sulfonyl)- 2,4- dichlorobenzamideIBA 02/2015
1	rilotumumabIBA 08/2014
1	ganitumabIBA 08/2014
1	human ERBB2 proteinIBA 10/2013
1	Lapatinib (GW572016)FDA Link 10/2013
1	Esomeprazole (Nexium)FDA Link 10/2013
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2013
1	Tyrosine Kinase InhibitorsIBA 03/2013
1	pazopanib FDA Link 03/2013
1	HomoharringtonineIBA 01/2013
1	OGX-011IBA 03/2012
1	ClusterinIBA 03/2012
1	PlatinumIBA 03/2012
1	Proteins (Proteins, Gene)FDA Link 03/2012
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2011
1	Endothelin A ReceptorIBA 09/2011
1	ZD4054IBA 09/2011
1	Biological ProductsIBA 08/2011
1	Peptides (Polypeptides)IBA 08/2011
1	Fluorouracil (Carac)FDA LinkGeneric 06/2011
1	PHY 906IBA 06/2011
1	Plant Preparations (Preparation, Plant)IBA 06/2011
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2011
1	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 08/2010
1	Dacarbazine (DIC)FDA LinkGeneric 08/2010
1	talabostatIBA 07/2009
1	EpitopesIBA 09/2008
1	VaccinesIBA 09/2008
1	AntigensIBA 09/2008
1	IDM 2101IBA 09/2008

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 02/2015 - 08/2010
1	Castration 09/2011
1	Intravenous Administration 08/2011
1	Intravenous Infusions 08/2011
1	Therapeutics 08/2011
1	Immunotherapy 09/2008